Target intelligence / Profile preview

Staphylococcal surface proteins

Molecular classification
Surface protein, Adhesin, Virulence factor, Receptor
01

Overview

Staphylococcal surface proteins are a diverse group of molecules, primarily cell wall-anchored (CWA) proteins, that play a fundamental role in the pathogenesis of Staphylococcus aureus and other staphylococci (Foster et al., 2014). These proteins, often categorized as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), facilitate bacterial attachment to host extracellular matrix components like fibrinogen, fibronectin, and collagen (Speziale et al., 2009). Beyond adhesion, they are instrumental in immune evasion—for instance, Protein A (Spa) binds the Fc region of antibodies to prevent opsonization—and in nutrient acquisition, such as the Isd proteins involved in heme-iron scavenging (Foster et al., 2014). Because of their essential roles in colonization and survival within the host, these proteins are primary targets for the development of vaccines and monoclonal antibodies (Speziale et al., 2009). However, the high degree of functional redundancy among different surface proteins has historically complicated the development of effective single-target therapies, leading to a shift toward multi-component strategies (Fowler et al., 2013).

Other names
Microbial surface components recognizing adhesive matrix moleculesMSCRAMMsCell wall-anchored proteinsCWA proteinsStaphylococcal adhesinsSurface-associated proteins
02

Mechanism of action

Inhibition of bacterial attachment to host tissues, promotion of opsonophagocytosis by the immune system, and neutralization of immune-evasive functions such as immunoglobulin binding.

03

Biological functions

Cell adhesionImmune evasionBiofilm formationHost colonizationIron acquisitionInvasion
04

Disease associations

InfectionSepsisEndocarditisOsteomyelitisSkin and soft tissue infectionsBacteremia
05

Safety considerations

Redundancy of surface proteins leading to therapeutic escapeHigh failure rate in clinical trialsPotential for interference with commensal microfloraAntigenic variation among strainsPotential for pro-inflammatory responses
06

Interacting drugs

Tefibazumab

5 more in the full profile.

07

Biomarkers

Anti-ClfA antibody levelsAnti-Spa antibody levelsStaphylococcal DNA detectionC-reactive protein (CRP)

Beyond the preview

Go deeper on Staphylococcal surface proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Staphylococcal surface proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call